Viyash completes acquisition of Italy’s BioForLife Italia
As filed · Viyash Scientific Limited has informed the Exchange about Completion of acquisition of BioForLife Italia S.r.l
M&AImprovingNotablemateriality 64 out of 100
What happened
FactViyash Scientific’s step-down wholly owned subsidiary, Alivira Animal Health Limited, Ireland, completed the acquisition of 100% of BioForLife Italia S.r.l. on October 1, 2026. BioForLife Italia is now a step-down wholly owned subsidiary of Viyash, with Alivira representatives appointed to its board.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
Watch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- And we see good opportunity in the next 3 to 5 years. (management committed by H1 FY27)
- But definitely, 3 years, we can take comfortably 20% CAGR growth top line. (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- The completed transaction adds BioForLife Italia to Viyash’s wholly owned group structure. Final deferred consideration remains subject to closing-date net financial position adjustments.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%